CureDuchenne Ventures LLC Company Profile

16:16 EDT 20th June 2019 | BioPortfolio

CureDuchenne Ventures LLC collaborates with pharmaceutical and biotechnology companies to facilitate the development of drugs to treat Duchenne muscular dystrophy. CureDuchenne Ventures LLC was formed by CureDuchenne, a national nonprofit that has funded seven research projects that have advanced to human clinical trials. CureDuchenne has leveraged $100 million in pharma and biotech research and development investments. Now three of the projects CureDuchenne supported with funding, BioMarin Pharmaceutical, Sarepta Therapeutics and PTC Therapeutics, are the closest to becoming the first drugs to be approved for the treatment of the disorder. CureDuchenne has been working to treat the whole disease with a multi-pronged approach to find treatments for the many effects that Duchenne has on the body.

News Articles [255 Associated News Articles listed on BioPortfolio]

Patient relationship management startup Welkin Health raises $17.5M Series B round

Altos Ventures led the round while existing investors Thrive Capital, Red Swan Ventures and Asset Management Ventures also participated.

Redox Lands $33M for Scalable Healthcare Data Interoperability Platform

Redox, a Madison, WI-based company that is changing the way healthcare providers and software vendors share data has raised $33 million in Series C funding led by Battery Ventures. The Series C round ...

Unite Us Raises $35M for Care Coordination & Outcome Tracking Platform

Unite Us, a NYC-based care coordination and outcome tracking platform connecting healthcare and social service providers has raised $35 million in Series B funding. The funding round was led by Oak HC...

Nonprofit CureDuchenne is Encouraged to See Gene Editing for Duchenne Advance Through Vertex’s Acquisition of Exonics Therapeutics

Deal will accelerate drug development for Duchenne muscular dystrophy, a rare disease that affects 300,000 boys and young men worldwide CureDuchenne, a nonprofit...

Kymera closes $65mm Series B round

Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture Partners, 6 Dimensions Capital, and Pfizer Venture Investments co-led and ...

The Importance of Funding Early Innovation. Roel Bulthuis, Head of MS Ventures.

MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. They invest globally in emerging biotechnology companies that develop products ...

Diameter Health Raises $9.6M to Expand Clinical Data Integration Platform

Strategic Investment Made by Optum Ventures Will Support Product and Marketing for Clinical Data Integration Platform Diameter Health, a Farmington, CT-based provider of clinical data integration solu...

PSJH spinout Xealth pulls in $11M for digital prescribing platform

The Series A funding came from a slew of investors, including Novartis, Philips, McKesson Ventures, ResMed, Providence Ventures and UPMC.

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Psyche Meets the Gatekeepers: Creating a More Humane Culture for Women in Medicine.

In the Greek myth of Psyche and Eros, Psyche must fulfill four seemingly impossible tasks to achieve full consciousness before she can be reunited with her bridegroom, Eros. From early childhood, girl...

Beyond the Present Constraints That Prevent a Wide Spread of Tissue Engineering and Regenerative Medicine Approaches.

Despite the success of tissue engineered medical products (TEMPs) in preclinical translational research, very few have had success in the clinical market place. This gap, referred to as the "valley of...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [600 Associated Companies listed on BioPortfolio]

CureDuchenne Ventures LLC

CureDuchenne Ventures LLC collaborates with pharmaceutical and biotechnology companies to facilitate the development of drugs to treat Duchenne muscular dystrophy. CureDuchenne Ve...


CureDuchenne is a nonprofit organization that raises awareness and funds specifically aimed at taking on Duchenne Muscular Dystrophy (DMD). By working closely with the world’...

Cure Duchenne

Cure Duchenne, a national nonprofit organization located in Newport Beach, Calif., is gaining international attention for its efforts to raise funds and awareness for Duchenne â...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

More Information about "CureDuchenne Ventures LLC" on BioPortfolio

We have published hundreds of CureDuchenne Ventures LLC news stories on BioPortfolio along with dozens of CureDuchenne Ventures LLC Clinical Trials and PubMed Articles about CureDuchenne Ventures LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureDuchenne Ventures LLC Companies in our database. You can also find out about relevant CureDuchenne Ventures LLC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Corporate Database Quicklinks

Searches Linking to this Company Record